The EMCDDA Scientific Committee is set up by Article 13 of Regulation (EC) No 1920/2006 of the European Parliament and of the Council on the European Monitoring Centre for Drugs and Drug Addiction (as amended by regulation (EU) 2017/2101).
The task of the Scientific Committee is to assist the Management Board and the Director of the EMCDDA by delivering an opinion on any scientific matter concerning the Centre's activity which the Management Board or the Director may submit to it.
In addition, the risk assessment of new psychoactive substances is carried out by the Scientific Committee, in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended by regulation (EU) 2017/2101). In carrying out the risk assessment of new psychoactive substances, the Scientific Committee (extended, as required) needs to be able to assess public health and social risks posed by new psychoactive substances.
The rules applicable to the EMCDDA Scientific Committee require that its members are nationals of a Member State of the European Union (EU) or of a Country which has concluded an agreement with the latter for the purpose of the participation in the work of the EMCDDA. This requirement is a condition of eligibility for the selection and the appointment of the members of the EMCDDA Scientific Committee. If this condition is not met, this will determine the exclusion of the concerned person from the selection process and/or the termination of his/her appointment as member of the EMCDDA Scientific Committee, from the moment when the above referred condition is not met.
With regard to the above, and by taking into account the on-going process concerning the withdrawal of the United Kingdom (UK) from the EU (Brexit), United Kingdom’s nationals will no longer satisfy this condition as of the date of this withdrawal, to be determined in accordance with Article 50 of the Treaty of the European Union (TFEU). However, if at this date the Agreement to be concluded between the EU and the UK on this withdrawal (Withdrawal Agreement, as endorsed by the European Council on 25 November 2018) enters into force, United Kingdom’s nationals will be considered to meet the aforementioned condition of nationality during the transition period established by this Agreement.